Is there tonic activity in the endogenous opioid systems? A c-Fos study in the rat central nervous system after intravenous injection of naloxone or naloxone-methiodide.
about
Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.Extracellular signal-regulated kinase activation in the amygdala mediates elevated plus maze behavior during opioid withdrawalMu-opioid receptors selectively regulate basal inhibitory transmission in the central amygdala: lack of ethanol interactions.Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal.Sensitivity to naloxone of the behavioral signs of morphine withdrawal and c-Fos expression in the rat CNS: a quantitative dose-response analysis.Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawal.Baclofen did not modify sexually dimorphic c-Fos expression during morphine withdrawal syndrome.Differential respiratory control of the upper airway and diaphragm muscles induced by 5-HT1A receptor ligands.
P2860
Q35050888-3DAF6A42-1B44-4C2F-A058-D5AFE4AE89B9Q35658836-EDDC2A53-E8EE-4033-BFC3-56CEE8C54940Q35828180-CE3E018A-19AA-4F6E-A86D-938CF29E23E8Q37201365-28591EDE-7387-470F-915E-85A6A186003EQ43263235-F73136A0-BE2F-4EAD-A196-02291BC2955AQ43563196-BFEC59A3-6718-406E-AA5B-B35F7F398DF9Q44197990-05EB43EA-11ED-4EB8-BFF0-6D96A7909FAFQ44332725-2ACBE6F3-AFA4-4BEA-9E0C-6CC1ED47883FQ44341922-917D7A2B-7480-4BFA-8C05-7E4627DF8E03Q44574120-FC9A21AD-E070-475F-B429-E6554A1BDCA5Q45918994-BF641882-7E01-4750-9B64-703D0C00FCA8Q48296997-9139302D-4789-470E-BEC6-8AACCC53D03C
P2860
Is there tonic activity in the endogenous opioid systems? A c-Fos study in the rat central nervous system after intravenous injection of naloxone or naloxone-methiodide.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Is there tonic activity in the ...... loxone or naloxone-methiodide.
@en
Is there tonic activity in the ...... loxone or naloxone-methiodide.
@nl
type
label
Is there tonic activity in the ...... loxone or naloxone-methiodide.
@en
Is there tonic activity in the ...... loxone or naloxone-methiodide.
@nl
prefLabel
Is there tonic activity in the ...... loxone or naloxone-methiodide.
@en
Is there tonic activity in the ...... loxone or naloxone-methiodide.
@nl
P2860
P1476
Is there tonic activity in the ...... loxone or naloxone-methiodide.
@en
P2093
P2860
P304
P356
10.1002/1096-9861(20001113)427:2<285::AID-CNE9>3.0.CO;2-T
P407
P577
2000-11-01T00:00:00Z